Skip to Main Content

Author Details

Sofie V Nielsen
University of Copenhagen
2012
17
12
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36434153Lynch syndrome, molecular mechanisms and variant classification.Br J Cancer2023
35700725Disease-linked mutations cause exposure of a protein quality control degron.Structure2022
33886538Multiplexed assays reveal effects of missense variants in MSH2 and cancer predisposition.PLoS Genet2021
33779753Understanding the Origins of Loss of Protein Function by Analyzing the Effects of Thousands of Variants on Activity and Abundance.Mol Biol Evol2021
32759676Co-Chaperones in Targeting and Delivery of Misfolded Proteins to the 26S Proteasome.Biomolecules2020
33137092Folliculin variants linked to Birt-Hogg-Dubé syndrome are targeted for proteasomal degradation.PLoS Genet2020
30648773Toward mechanistic models for genotype-phenotype correlations in phenylketonuria using protein stability calculations.Hum Mutat2019
31697235Computational and cellular studies reveal structural destabilization and degradation of MLH1 variants in Lynch syndrome.Elife2019
28779490Blocking protein quality control to counter hereditary cancers.Genes Chromosomes Cancer2017
28422960Predicting the impact of Lynch syndrome-causing missense mutations from structural calculations.PLoS Genet2017
26966660Bioinformatics analysis identifies several intrinsically disordered human E3 ubiquitin-protein ligases.PeerJ2016
27613054High-Throughput siRNA Screening Applied to the Ubiquitin-Proteasome System.Methods Mol Biol2016
24497846A chaperone-assisted degradation pathway targets kinetochore proteins to ensure genome stability.PLoS Genet2014
25010148Protein quality control in the nucleus.Biomolecules2014
25078495Human ASPL/TUG interacts with p97 and complements the proteasome mislocalization of a yeast ubx4 mutant, but not the ER-associated degradation defect.BMC Cell Biol2014
24726323Molecular basis and regulation of OTULIN-LUBAC interaction.Mol Cell2014
23042605DVC1 (C1orf124) is a DNA damage-targeting p97 adaptor that promotes ubiquitin-dependent responses to replication blocks.Nat Struct Mol Biol2012
  • 1 - 17 of 17

Recommended Authors

European Bioinformatics Institute (EMBL-EBI)
Career Start Year 2015
Number of shared co-authors 1
College of Life Sciences, University of Dundee
Career Start Year 2013
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 2012
Number of shared co-authors 0
College of Medicine, Yangzhou University
Career Start Year 2010
Number of shared co-authors 0
Innovative Genomics Institute, University of California berkeley
Career Start Year 2009
Number of shared co-authors 1
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Career Start Year 2009
Number of shared co-authors 0
University of Regina
Career Start Year 2008
Number of shared co-authors 1
University of Zurich
Career Start Year 2005
Number of shared co-authors 0
David Geffen School of Medicine, University of California los angeles
Career Start Year 2005
Number of shared co-authors 1
Washington University in St. Louis
Career Start Year 2004
Number of shared co-authors 0
University of California Irvine
Career Start Year 2003
Number of shared co-authors 0
Erasmus Medical Center
Career Start Year 2000
Number of shared co-authors 0
College Street, University of Toronto
Career Start Year 2000
Number of shared co-authors 0
University of Washington and Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 2
Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke (CRCHUS)
Career Start Year 1999
Number of shared co-authors 0
University of Dundee
Career Start Year 1999
Number of shared co-authors 1
Salk Institute for Biological Studies
Career Start Year 1998
Number of shared co-authors 0
National Institute of Diabetes, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 0
Institute for Biotechnology, Technical University Berlin
Career Start Year 1998
Number of shared co-authors 1
Memorial Sloan-Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Friedrich Miescher Institute for Biomedical Research
Career Start Year 1997
Number of shared co-authors 0
David Geffen School of Medicine, University of California Los Angeles
Career Start Year 1996
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1994
Number of shared co-authors 0
Institute of Molecular Systems Biology, ETH Zurich
Career Start Year 1994
Number of shared co-authors 0
University of California Irvine
Career Start Year 1994
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1993
Number of shared co-authors 0
Harvard Medical School
Career Start Year 1991
Number of shared co-authors 0
Max Planck Institute for Multidisciplinary Sciences
Career Start Year 1982
Number of shared co-authors 0
Harvard Medical School
Career Start Year 1981
Number of shared co-authors 1
TheScripps Research Institute
Career Start Year 1960
Number of shared co-authors 1

Collaborators

University of Copenhagen
Co-authored papers 16
University of Copenhagen
Co-authored papers 5
Institute of Biochemistry and Molecular Biology, University of Freiburg
Co-authored papers 2
University of Washington, USA Brotman Baty Institute for Precision Medicine
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Clinical and Health Sciences, University of South Australia
Co-authored papers 1
University of California, USA Quantitative Biosciences Institute (QBI) san francisco
Co-authored papers 1
Heinrich-Heine-Universitat Dusseldorf
Co-authored papers 1
The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Co-authored papers 1
Institute of Functional Microbial Genomics, Heinrich-Heine-University
Co-authored papers 1
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Co-authored papers 1